Introduction of mutations into the non-structural genes or 3′ untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity
- 3 September 2004
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 22 (25-26), 3440-3448
- https://doi.org/10.1016/j.vaccine.2004.02.031
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeysVaccine, 2003
- A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3′ Untranslated Region Is Highly Attenuated and Immunogenic in MonkeysJournal of Virology, 2003
- Human Arbovirus Infections WorldwideAnnals of the New York Academy of Sciences, 2001
- Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.The American Journal of Tropical Medicine and Hygiene, 2001
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001
- Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French PolynesiaJournal of Medical Virology, 2000
- Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease SeverityThe Journal of Infectious Diseases, 2000
- Dengue and Dengue Hemorrhagic FeverClinical Microbiology Reviews, 1998
- Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteersVaccine, 1996
- Selection of Attenuated Dengue 4 Viruses by Serial Passage in Primary Kidney CellsThe American Journal of Tropical Medicine and Hygiene, 1984